The project will investigate the mechanisms of a new clinical drug combination currently in clinical trials for ... short feedback survey or if you have any questions, please contact Dr Koh on ...
Merus leads biotech with its innovative antibody platforms, strong financials, and promising petosemtamab targeting cancer.
News-Medical.Net on MSN5h
Blocking an enzyme to overcome immunotherapy resistance in melanoma patientsAbout 65% of melanoma patients do not respond to immunotherapy. New work by the team of Prof. Max Mazzone (VIB-KU Leuven ...
About 65% of melanoma patients do not respond to immunotherapy. New work by the team of Prof. Max Mazzone (VIB-KU Leuven ...
Learn why cravings feel uncontrollable and discover simple strategies to take back control of your eating habits and feel ...
ConferenceBIOVERSYS TO PRESENT BV100 PHASE 2 DATA AT 35TH ESCMID GLOBAL 2025 08.04.2025 / 07:00 CET/CESTBasel, Switzerland. April 08, 2025, 7am CEST. Oral presentation on April 13, 2025, highlighting ...
An international research group led by the Helmholtz Center for Infection Research (HZI) has discovered a promising new drug ...
Distinguished, highly accomplished clinician with stellar track record of successfully leading numerous registrational trials ...
Global development program for JNJ-1900 (NBTXR3) proceeding as planned, with opportunity to address one of the largest untapped markets in ...
Formulated by Leading Edge Health Research for Maximum Muscle Growth, Testosil Emerges as the #1 Testosterone Booster for Men ...
Mississippi made history by being the first state besides Alaska to eliminate its income tax. Here's how it happened.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback